NCT00002235

Tracking Information
First Received Date

  • November 2, 1999
Last Updated Date

  • June 23, 2005
Start Date

  •  
Estimated Primary Completion Date
Primary Outcome Measures
Secondary Outcome Measures
Descriptive Information
Brief Title

  • A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
Official Title
Detailed Description
Study Type
Study Phase
Study Design
Condition
Intervention
Study Arm (s)
References
Reqruitment Information
Recruitment Status
Estimated Enrollment
Estimated Primary Completion Date
Eligibility Criteria
Gender
Minimum Age
Maximum Age
Accepts Healthy Volunteers
Sampling Method
Contact(s)
Location Countries